Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Breath Therapeutics was founded in 2016. Breath Therapeutics' headquarters is located in Munich, Bavaria, DE 80639.
Breath Therapeu...
Breath Therapeutics's Co-Founder & CEO, Jens Stegemann, currently has an approval
rating of 90%. Breath Therapeutics's primary competitors are Synairgen, Verona Pharma & Enterprise Therapeutics.